Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
lisocabtagene maraleucel b-lymphocyte surface antigen b4 NA Successful target TTD B-Cell Lymphomas[MeSHID:D016393]
Diffuse Large B-Cell Lymphoma[MeSHID:D016403]
Lymphoma
Follicular[MeSHID:D008224]
High Grade Lymphoma (neoplasm)[MeSHID:D008228]
B-Lymphocytes[MeSHID:D001402]
Relapse[MeSHID:D012008]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Non-Hodgkin[MeSHID:D008228]
Lymphoma[MeSHID:D008223]
Neoplasms[MeSHID:D009369]
Syndrome[MeSHID:D013577]		 NA approved unknown
lisocabtagene maraleucel b-lymphocyte antigen cd19 biotech NA drugbank B-Cell Lymphomas[MeSHID:D016393]
Diffuse Large B-Cell Lymphoma[MeSHID:D016403]
Lymphoma
Follicular[MeSHID:D008224]
High Grade Lymphoma (neoplasm)[MeSHID:D008228]
B-Lymphocytes[MeSHID:D001402]
Relapse[MeSHID:D012008]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Non-Hodgkin[MeSHID:D008228]
Lymphoma[MeSHID:D008223]
Neoplasms[MeSHID:D009369]
Syndrome[MeSHID:D013577]		 NA approved binder
click here to return to the previous page